1575. Metabolomic study of candidemia
Session: Poster Abstract Session: Mycology: Diagnostic
Friday, October 28, 2016
Room: Poster Hall


Candidemia has emerged as an important nosocomial infection with mortality of 29~47%. No study assesses the differences in metabolic profiles between survivors and non-survivors with candidemia. The present study aimed to identify important metabolites to discriminate the two groups to optimize treatment. 


From 2011/7/18 to 2014/12/11, a total of 30 patients with candidemia caused by C. albicans who had blood samples collected within 4 days after the date of first positive blood culture for C. albicans (candidemia onset) were included for analysis. Mortality on Day 14 after candidemia onset was assessed, and metabolites from the blood samples of survivors and non-survivors were analyzed and compared by an Agilent 1290 UHPLC system coupled to a 6540-QTOF (Agilent Technologies, Santa Clara, CA, USA).


The enrolled patients had a median age of 62, a median APACH II score of 17, and a median Charlson index of 3. The mortality on Day 14 was 27%. Figure 1 shows the scatter plot of PLS-DA using 34 metabolites to discriminate 22 survivors from 8 non-survivors. 


Differences in metabolic profiling existed between non-survivors and survivors with candidemia.

Figure 1: Scatter plot of PLS-DA to dis discriminate 22 survivors from 8 non-survivors.  

Description: Macintosh HD:Users:jamie:Desktop:Screen Shot 2016-05-17 at 11.53.40 PM.png

Hsin-Yun Sun, M.D., Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan, San-Yuan Wang, Ph.D., Bioinformatics and Cheminformatics Lab, National Taiwan University Hospital, Taipei, Taiwan, Ching-Hua Kuo, Ph.D., School of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan, Yufeng Tseng, Ph.D., Department of Computer Science and Information Engineering, National Taiwan University Hospital, Taipei, Taiwan and Yee-Chun Chen, M.D., Ph.D., Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan


H. Y. Sun, None

S. Y. Wang, None

C. H. Kuo, None

Y. Tseng, None

Y. C. Chen, None

See more of: Mycology: Diagnostic
See more of: Poster Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.